Reply to Tran et al.: Dimeric KRAS protein-protein interaction stabilizers
Proc Natl Acad Sci U S A
.
2020 Feb 18;117(7):3365-3367.
doi: 10.1073/pnas.1921236117.
Epub 2020 Feb 11.
Authors
Dirk Kessler
1
,
Andreas Gollner
1
,
Michael Gmachl
1
,
Andreas Mantoulidis
1
,
Laetitia J Martin
1
,
Andreas Zoephel
1
,
Moriz Mayer
1
,
David Covini
1
,
Silke Fischer
1
,
Thomas Gerstberger
1
,
Teresa Gmaschitz
1
,
Craig Goodwin
2
,
Peter Greb
1
,
Daniela Häring
1
,
Wolfgang Hela
1
,
Johann Hoffmann
1
,
Jale Karolyi-Oezguer
1
,
Petr Knesl
1
,
Stefan Kornigg
1
,
Manfred Koegl
1
,
Roland Kousek
1
,
Lyne Lamarre
1
,
Franziska Moser
3
,
Silvia Munico-Martinez
1
,
Christoph Peinsipp
1
,
Jason Phan
2
,
Jörg Rinnenthal
1
,
Jiqing Sai
2
,
Christian Salamon
1
,
Yvonne Scherbantin
1
,
Katharina Schipany
1
,
Renate Schnitzer
1
,
Andreas Schrenk
1
,
Bernadette Sharps
1
,
Gabriella Siszler
1
,
Qi Sun
2
,
Alex Waterson
4
5
,
Bernhard Wolkerstorfer
1
,
Markus Zeeb
3
,
Mark Pearson
1
,
Stephen W Fesik
2
4
5
,
Darryl B McConnell
6
Affiliations
1
Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
2
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37235.
3
Discovery Research, Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach an der Riss, Germany.
4
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37235.
5
Department of Chemistry, Vanderbilt University, Nashville, TN 37235.
6
Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria; darryl.mcconnell@boehringer-ingelheim.com.
PMID:
32047042
PMCID:
PMC7035485
DOI:
10.1073/pnas.1921236117
No abstract available
Publication types
Letter
Comment
MeSH terms
Proto-Oncogene Proteins p21(ras)*
Substances
Proto-Oncogene Proteins p21(ras)